APVO 8-K: Material agreement
Aptevo Therapeutics
Filed with the SEC on · accession 0001193125-26-458751
APVO filed a 8-K (current report) with the SEC on Nov 12, 2026. Aptevo Therapeutics entered into Warrant Inducement and Reload Letters with certain holders of its existing warrants, who agreed to exercise existing warrants for 2,777,778 shares at a reduced price of $1.08 per share, generating approximately $3.0 million in gross proceeds. The stock moved -13.1% by the first close after the filing.
Summary of the filing
Aptevo Therapeutics entered into Warrant Inducement and Reload Letters with certain holders of its existing warrants, who agreed to exercise existing warrants for 2,777,778 shares at a reduced price of $1.08 per share, generating approximately $3.0 million in gross proceeds. In exchange, the company issued new inducement warrants to purchase up to 13,888,890 shares at $1.08 per share, which could yield an additional $15.0 million if fully exercised.
Key details
How APVO stock reacted
Close before
$0.76
Nov 11, 2026
First close after
-13.14%
$0.66
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for APVO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for APVO?
Click hereFrequently asked questions
What did APVO file with the SEC on Nov 12, 2026?
APVO filed a 8-K (Material agreement). Aptevo Therapeutics entered into Warrant Inducement and Reload Letters with certain holders of its existing warrants, who agreed to exercise existing warrants for 2,777,778 shares at a reduced price of $1.08 per share, generating approximately $3.0 million in gross proceeds. In exchange, the company issued new inducement warrants to purchase up to 13,888,890 shares at $1.08 per share, which could yield an additional $15.0 million if fully exercised.
What does a material agreement mean for APVO stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did APVO stock react to this filing?
APVO closed at $0.76 before the filing and $0.66 on Nov 12, 2026 (-13.14%).
Other APVO SEC filings
- 8-K · SEC filingNov 9, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Shelf registrationNov 2, 2026
- 424B5 · Shelf registrationOct 30, 2026
- 8-K · SEC filingOct 26, 2026
- 8-K · Material agreementOct 23, 2026
- 8-K · SEC filingOct 14, 2026
- 8-K · Fda approvalSep 24, 2026
- 8-K · SEC filingSep 23, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
Get alerts when APVO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days